BioTech
Private equity and neuroscience: a novel approach to developing new treatments for neurological disorders
Neurological diseases are now the leading cause of poor health and disability worldwide. An estimated 3.4 billion people, or 40% of the world’s population, are
Bruce Leuchter
July 9, 2024